Search

everythinglearnresearchcommunity

for

Search:↓

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Loose Anagen Syndrome causes easy-to-pull, thin hair, mainly in young girls, and improves with age.

Hair restoration surgery can have complications; success depends on patient education, careful planning, and proper execution.

Multimodal minoxidil microemulsion is more effective in treating hair loss than minoxidil alone.

Finasteride improves surrounding scalp hair and increases hair density after hair transplant.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Different human hair follicle stem cells grow at different rates and respond differently to a baldness-related compound.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

Sargassum muticum extract and its component apo-9'-fucoxanthinone may help hair growth and treat hair loss.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Animal models are crucial for learning about hair loss and finding treatments.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Bee venom helps hair grow and may work better than some common treatments.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Minoxidil inside tiny particles can deliver more drug to hair follicles, potentially improving treatment for hair loss.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.